Genentech Oncology
GO BEYOND THE SCIENCE
Advancing Precision Medicine
Genentech has boldly led the way in the precision medicine space—working toward a goal of every patient having timely access to treatment that is precisely right for them. Today, we continue to GO forward in several areas:
The development of molecules
that target specific biomarkers to help deliver more personalized care
Education for policymakers
on the value of patient access to and insurance coverage of biomarker testing
Education
on up-to-date, guidelines-based information about actionable and emerging biomarkers and the importance of comprehensive testing in the evolving therapeutic landscape
Using real world evidence
to track the progress of precision medicine, including clinical and economic outcomes
Featured Initiatives:
Shining a Light on Disparities in Access to Comprehensive Biomarker Testing
Genentech forged a first-of-its-kind collaboration with OneOncology, with the goal of developing, testing, and sharing solutions to both provide personalized cancer care in communities nationwide and reduce disparities in access to that care.
View the full case study to learn more about our efforts to reveal inequities in testing.
Reducing Healthcare Disparities Through Public Policy
In collaboration with healthcare advocacy groups, we are educating state and federal policymakers about the clinical value of biomarker testing, with the aim of gaining support for legislation that improves equitable access to testing.
View the full case study to learn more about our policy efforts to support biomarker testing.
Other initiatives and resources include:
Education through BiomarkerTesting.com
Biomarker testing is an important first step in the diagnosis of certain cancers and, in some cases, has redefined the therapeutic landscape. Explore our biomarkertesting.com site to find educational resources, guidelines, and related coverage information on biomarker testing for healthcare professionals.
Learn more about biomarker testing.
LUNGevity’s No One Missed campaign
Genentech proudly sponsors LUNGevity’s No One Missed campaign
A community-led, collaborative initiative to build public awareness of comprehensive biomarker testing as a critical part of every non-small cell lung cancer diagnosis, educate providers, and empower patients to discuss comprehensive biomarker testing with their healthcare team. LUNGevity is a patient advocacy organization transforming how people live with lung cancer through research, education, and support.
Learn more about how this campaign can help educate your providers and patients.
A Breath of Hope Lung Foundation
Proudly Supported by Genentech through a Patient Focused Giving Grant
A diagnosis of non–small cell lung cancer (NSCLC) can be overwhelming for patients and for those treating them. Since 2012, Genentech has supported, through corporate giving grants, A Breath of Hope Lung Foundation’s work to increase awareness and education, with a particular focus on reaching underrepresented and marginalized communities and increased support of patients who often face this cancer with little or no support. Expert-led educational videos on biomarker testing are available to empower your patients to learn more and take control of their NSCLC diagnosis.
These videos are independently developed by A Breath of Hope Lung Foundation. Genentech does not control and is in no way responsible for the content.
Empower your patients to learn more about biomarker testing.